These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 8311539

  • 1. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
    Matsumoto T, Iwasaki K.
    Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
    [Abstract] [Full Text] [Related]

  • 2. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 3. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
    Carotti M, Salaffi F, Ferraccioli GF, Binci MC, Sartini A, Cervini C.
    Rheumatol Int; 1994 Mar; 14(2):47-52. PubMed ID: 7824835
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J.
    Clin Exp Rheumatol; 2003 Mar; 21(1):63-9. PubMed ID: 12673891
    [Abstract] [Full Text] [Related]

  • 5. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA, Wood NC, Di Giovine FS, Duff GW.
    J Immunol; 1988 Oct 15; 141(8):2612-8. PubMed ID: 3262665
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, Fontan G.
    J Rheumatol; 1997 Nov 15; 24(11):2069-75. PubMed ID: 9375862
    [Abstract] [Full Text] [Related]

  • 9. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.
    Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA.
    Arthritis Rheum; 1988 Jul 15; 31(7):844-9. PubMed ID: 3134896
    [Abstract] [Full Text] [Related]

  • 12. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
    Liu DF, Yan J, Guo MY, Wang C, Hu YH, Yang M, Yun MD, Luo Y, Zhang J, Li H.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar 15; 34(3):272-5. PubMed ID: 24758074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.
    Yoo IS, Lee SY, Park CK, Lee JC, Kim Y, Yoo SJ, Shim SC, Choi YS, Lee Y, Kang SW.
    Int J Rheum Dis; 2018 Jan 15; 21(1):148-154. PubMed ID: 27315340
    [Abstract] [Full Text] [Related]

  • 15. [Soluble IL-2 receptor levels in rheumatic diseases].
    Takaya M, Ichikawa Y, Shimizu H, Uchiyama M, Moriuchi J, Arimori S.
    Ryumachi; 1993 Jun 15; 33(3):229-34. PubMed ID: 8346465
    [Abstract] [Full Text] [Related]

  • 16. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
    Herzog C, Herzog A, Aeschlimann A, Gerber H, Müller W.
    Z Rheumatol; 1990 Jun 15; 49(1):8-10. PubMed ID: 2327181
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis.
    Hasunuma T, Kayagaki N, Asahara H, Motokawa S, Kobata T, Yagita H, Aono H, Sumida T, Okumura K, Nishioka K.
    Arthritis Rheum; 1997 Jan 15; 40(1):80-6. PubMed ID: 9008603
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X, Zhao J, Liu R, Jia R, Sun L, Li X, Li Z.
    Scand J Rheumatol; 2013 Jan 15; 42(2):97-101. PubMed ID: 23311967
    [Abstract] [Full Text] [Related]

  • 19. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
    Crilly A, Madhok R, Watson J, Capell HA.
    Ann Rheum Dis; 1993 Jan 15; 52(1):58-60. PubMed ID: 8093995
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
    Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen JS.
    J Rheumatol; 1998 Jan 15; 25(1):105-10. PubMed ID: 9458212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.